SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 301 filers reported holding SEATTLE GENETICS INC in Q2 2017. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $268,918,000 | +15.8% | 1,375,385 | +0.5% | 0.05% | +6.0% |
Q2 2020 | $232,277,000 | +37.4% | 1,368,165 | -6.7% | 0.05% | +13.6% |
Q1 2020 | $169,001,000 | -46.5% | 1,465,893 | -47.0% | 0.04% | +33.3% |
Q4 2019 | $315,732,000 | +193.8% | 2,765,682 | +119.7% | 0.03% | +32.0% |
Q3 2019 | $107,457,000 | +28.1% | 1,259,131 | +3.8% | 0.02% | +25.0% |
Q2 2019 | $83,869,000 | -3.0% | 1,212,636 | +2.7% | 0.02% | -9.1% |
Q1 2019 | $86,437,000 | -31.6% | 1,181,056 | -47.1% | 0.02% | +10.0% |
Q4 2018 | $126,392,000 | +56.7% | 2,232,114 | +113.2% | 0.02% | -13.0% |
Q3 2018 | $80,674,000 | +19.2% | 1,046,806 | +2.6% | 0.02% | +9.5% |
Q2 2018 | $67,655,000 | +32.4% | 1,019,827 | +4.4% | 0.02% | +23.5% |
Q1 2018 | $51,089,000 | +10.8% | 976,886 | +13.3% | 0.02% | +6.2% |
Q4 2017 | $46,104,000 | -1.0% | 862,272 | +0.7% | 0.02% | -5.9% |
Q3 2017 | $46,583,000 | +8.4% | 856,507 | +3.1% | 0.02% | 0.0% |
Q2 2017 | $42,969,000 | -14.0% | 830,806 | +4.5% | 0.02% | -19.0% |
Q1 2017 | $49,976,000 | +29.0% | 795,339 | +8.3% | 0.02% | +16.7% |
Q4 2016 | $38,754,000 | -0.8% | 734,643 | +1.6% | 0.02% | -10.0% |
Q3 2016 | $39,067,000 | +31.9% | 723,348 | -1.3% | 0.02% | +25.0% |
Q2 2016 | $29,626,000 | +18.7% | 733,149 | +3.0% | 0.02% | +23.1% |
Q1 2016 | $24,965,000 | -15.6% | 711,458 | +7.9% | 0.01% | -23.5% |
Q4 2015 | $29,593,000 | +24.1% | 659,393 | +6.6% | 0.02% | +21.4% |
Q3 2015 | $23,846,000 | -16.7% | 618,437 | +4.5% | 0.01% | -12.5% |
Q2 2015 | $28,643,000 | +42.9% | 591,812 | +4.4% | 0.02% | +45.5% |
Q1 2015 | $20,042,000 | +12.4% | 566,979 | +2.1% | 0.01% | 0.0% |
Q4 2014 | $17,835,000 | -15.7% | 555,125 | -2.4% | 0.01% | -21.4% |
Q3 2014 | $21,154,000 | -3.8% | 568,987 | -1.0% | 0.01% | 0.0% |
Q2 2014 | $21,987,000 | -13.9% | 574,841 | +2.6% | 0.01% | -17.6% |
Q1 2014 | $25,529,000 | +17.5% | 560,357 | +2.9% | 0.02% | +13.3% |
Q4 2013 | $21,729,000 | +7.5% | 544,729 | +18.1% | 0.02% | -6.2% |
Q3 2013 | $20,222,000 | +44.5% | 461,380 | +3.7% | 0.02% | +33.3% |
Q2 2013 | $13,995,000 | – | 444,840 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 51,046,060 | $2,892,270,000 | 23.68% |
Lagoda Investment Management, L.P. | 88,615 | $5,021,000 | 8.38% |
Matrix Capital Management Company, LP | 3,141,852 | $178,017,000 | 5.90% |
Opus Point Partners Management, LLC | 19,127 | $1,084,000 | 2.39% |
EMORY UNIVERSITY | 41,539 | $2,354,000 | 1.86% |
Capital International Sarl | 238,100 | $13,491,000 | 1.62% |
Rhenman & Partners Asset Management AB | 242,198 | $13,723,000 | 1.57% |
CAPITAL GUARDIAN TRUST CO | 1,341,050 | $75,984,000 | 1.21% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 42,500 | $1,890,000 | 1.17% |
JGP Global Gestao de Recursos Ltda. | 16,524 | $936,000 | 1.14% |